We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Parallel Impedance Cytometry Screens Bacterial Cells in Real Time

By LabMedica International staff writers
Posted on 25 Oct 2022
Print article
Image: Schematic of the intelligent impedance system, consisting of a parallel impedance cytometry and a machine learning-based detection system (Photo courtesy of Yaxiaer Yalikun, PhD)
Image: Schematic of the intelligent impedance system, consisting of a parallel impedance cytometry and a machine learning-based detection system (Photo courtesy of Yaxiaer Yalikun, PhD)

Antibiotic-resistant infections are responsible for killing over a million people worldwide every year. Central to managing resistant infections is quickly identifying an appropriate treatment to which the infective bacteria are susceptible. Significant time is needed to determine the drug susceptibility profile of a bacterial infection.

Impedance cytometry measures the dielectric properties of individual cells with high throughput, over a thousand cells per minute. Because the electrical readout of a bacterium corresponds to its physical response to an antibiotic, one has a straightforward means of determining whether the antibiotic works against the bacteria.

Scientists at the Nara Institute of Science and Technology (Ikoma, Japan) developed a novel impedance cytometry method that simultaneously analyses the test and reference particles in separate channels, creating easily analyzable separate datasets. This cytometry had nanoscale sensitivity, allowing for detection of even minute physical changes in bacterial cells. The group designed a machine learning tool to analyze the impedance cytometry data. Because the new cytometry method splits the test and reference datasets, the machine learning tool could automatically label the reference dataset as the “learning” dataset and use it to learn the characteristics of an untreated bacterium. By real-time comparison with antibiotic-treated cells, the tool can identify whether the bacteria are susceptible to the drug and can even identify what proportion of bacterial cells are resistant in a mixed-resistance population.

Target objects can be detected even when benchmarked against similar objects. Parallel dual microchannels allow the simultaneous detection of reference and target particles in two separate microchannels, without the premixing of reference and target suspensions. The impedance pulses of both can appear separately on the opposite sides of the same time series, which have been verified via simulation and experimental results. Raw impedance signals can easily distinguish target particles from reference ones. Polystyrene beads with different sizes ranging from nano- to microscale (e.g., 500, 750 nm, 1, 2, 3, and 4.5 μm) confirm the nanosensitivity of the system. In addition, the detection of antibiotic-treated Escherichia coli cells demonstrates that the system can be used for the quantitative assessment of the dielectric properties of individual cells, as well as for the proportion of susceptible cells.

Yoichiroh Hosokawa, PhD, an Assistant Professor and a senior author of the study, said, “Although there was a misidentification error of less than 10% in our work, there was a clear discrimination between susceptible and resistant cells within two hours of antibiotic treatment.”

The authors concluded that their findings indicate that the parallel impedance cytometry can greatly facilitate the measurement and calibration of the impedances of various particles or cells and provide a means to compare their dielectric properties. The study was published on October 6, 2022 in the journal ACS Sensors.

Related Links:
Nara Institute of Science and Technology

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.